FDA Inspection 1069250 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Sep 19, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)